tiprankstipranks
Neurocrine (NBIX)
NASDAQ:NBIX
US Market

Neurocrine (NBIX) Income Statement

Compare
1,348 Followers

Neurocrine Income Statement

Last quarter (Q4 2024), Neurocrine's total revenue was $627.70M, an increase of 21.84% from the same quarter last year. In Q4, Neurocrine's net income was $103.10M. See Neurocrine’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 2.36B$ 1.89B$ 1.49B$ 1.13B$ 1.05B
Gross Profit
$ 2.32B$ 1.85B$ 1.47B$ 1.12B$ 1.04B
Operating Expenses
$ 1.75B$ 1.60B$ 1.22B$ 911.40M$ 708.30M
Depreciation and Amortization
$ 27.10M$ 21.30M$ 15.60M$ 10.90M$ 8.60M
EBITDA
$ 610.10M$ 358.00M$ 264.60M$ 218.70M$ 336.10M
Operating Income
$ 570.50M$ 250.90M$ 249.00M$ 196.90M$ 318.90M
Other Income/Expenses
$ -84.50M$ 81.20M$ -35.10M$ -1.10M$ -56.30M
Pretax Income
$ 486.00M$ 332.10M$ 213.90M$ 101.40M$ 106.70M
Net Income
$ 341.30M$ 249.70M$ 154.50M$ 89.60M$ 407.30M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ 3.40$ 2.56$ 1.61$ 0.95$ 4.37
Diluted EPS
$ 3.29$ 2.47$ 1.56$ 0.92$ 4.16
Weighted Average Shares Outstanding
100.40M 97.70M 95.80M 94.60M 93.10M
Weighted Average Shares Outstanding (Diluted)
103.70M 101.00M 98.90M 97.90M 97.80M
Currency in USD

Neurocrine Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis